1. Home
  2. CREX vs EVAX Comparison

CREX vs EVAX Comparison

Compare CREX & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

HOLD

Current Price

$3.95

Market Cap

39.1M

Sector

Technology

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.69

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREX
EVAX
Founded
N/A
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
32.7M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
CREX
EVAX
Price
$3.95
$3.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
33.2K
28.0K
Earning Date
04-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
2.86
N/A
EPS
N/A
N/A
Revenue
$18,437,000.00
N/A
Revenue This Year
$81.98
N/A
Revenue Next Year
$14.82
$328.20
P/E Ratio
N/A
N/A
Revenue Growth
5.61
N/A
52 Week Low
$2.19
$2.11
52 Week High
$4.42
$12.15

Technical Indicators

Market Signals
Indicator
CREX
EVAX
Relative Strength Index (RSI) 51.19 33.02
Support Level $3.52 $3.32
Resistance Level $3.81 $3.62
Average True Range (ATR) 0.26 0.18
MACD 0.00 -0.05
Stochastic Oscillator 63.11 10.96

Price Performance

Historical Comparison
CREX
EVAX

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: